NCT05420376 is a NA clinical trial of Split Mesh in Hernia, Inguinal, sponsored by Istanbul Training and Research Hospital.

Who is sponsoring NCT05420376?

NCT05420376 is sponsored by Istanbul Training and Research Hospital.

What drugs are being tested in NCT05420376?

Interventions in NCT05420376: Split Mesh.

What condition does NCT05420376 study?

NCT05420376 studies Hernia, Inguinal.

Is NCT05420376 still recruiting?

NCT05420376 is currently status unknown. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT05420376

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Whole Mesh and Split Mesh Use in Laparoscopic Inguinal Hernia Repair

Status unknown NA Last updated 20 July 2022

What this trial tests

NA trial testing Split Mesh in Hernia, Inguinal in 80 participants. Status unknown.

Timeline

16 June 2022

Primary endpoint
16 May 2023

16 June 2023

Quick facts

Lead sponsor	Istanbul Training and Research Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	80
Start date	16 June 2022
Primary completion	16 May 2023
Estimated completion	16 June 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Split Mesh

Conditions studied

Hernia, Inguinal — all drugs for Hernia, Inguinal →

Sponsor

Istanbul Training and Research Hospital

Who can join

18 and older, any sex, with Hernia, Inguinal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At least 80 patients who will undergo laparoscopic inguinal hernia repair surgery will be randomized into 2 groups. For the patients in the first group, the whole mesh will be laid on the area without being fixed. The patients in the second group will be given a mesh of the same size, but partially divided horizontally and wrapped around the spermatic cord. Demographic data of patients in both groups, quality of life data(Carolinas Comfort Scale) at postoperative 1st, 7th, 30th, 3rd and 6th months, postoperative pain (VAS values), clinical seroma rate, recurrence and other complications will be monitored. When the desired number of patients and follow-up period are reached, the data in the 2 groups will be compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hernia, Inguinal

Currently open trials in the same condition.

NCT05934266 — Impact of Mesh Fixation With Tissue Adhesive · Phase 4 · active not recruiting
NCT05839587 — Transabdominal Preperitoneal Inguinal Hernia Repair · NA · active not recruiting
NCT05484635 — Mesh Removal Versus No Mesh Removal for Chronic Groin Pain After Inguinal Hernia Repair · NA · recruiting
NCT05216276 — Robotic vs. Conventional Minimal-invasive Inguinal Hernia Repair · NA · active not recruiting
NCT04779918 — Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh · NA · recruiting

Other Istanbul Training and Research Hospital trials

Trials by the same sponsor.

NCT07499713 — Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata · enrolling by invitation
NCT07335822 — The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica · NA · recruiting
NCT07363187 — Nailfold Capillaroscopy and Endothelial Biomarkers in Healthcare Workers Exposed to Chronic Low-Dose Ionizing Radiation · not yet recruiting
NCT07415291 — CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis · active not recruiting
NCT07150702 — Effects of Close Follow-up on Patients With Low Back Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05420376 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Training and Research Hospital
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05420376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing